A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2004
12/22/2004	CN1556698A Neuroprotective treatment methods using selective iNOS inhibitors
12/22/2004	CN1555842A Chinese medicine for expelling stasis
12/22/2004	CN1181201C LAG-3 splice variants
12/22/2004	CN1181094C Hemopoiesis factor and its application
12/22/2004	CN1181075C Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
12/22/2004	CN1181070C Urea substituted imidazoquinolines
12/22/2004	CN1181069C Novel inhibitors of farnesyl-protein transferase
12/22/2004	CN1181062C 2-phenoxy pyrimidine derivative and its use in treating disease
12/22/2004	CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same
12/22/2004	CN1181048C Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha
12/22/2004	CN1181043C Quaternary bis-ammonium salt precursors and their uses as prodrugs having antiparasitic activity
12/22/2004	CN1180839C Powdery preparation containing polymeric medicine for mucosal administration
12/22/2004	CN1180830C Chinese medicine preparation for curing conjunctival congestion, dizziness and flaming-up of liver-fire
12/22/2004	CN1180799C Deer fetus oral liquid and its preparation process
12/21/2004	US6833461 Process for preparing simvastatin
12/21/2004	US6833456 Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use
12/21/2004	US6833437 Complement receptor type 1 (CR1)-like sequences
12/21/2004	US6833436 Short peptides which selectively modulate the activity of serine/threonine kinases
12/21/2004	US6833381 TNF-α inhibitors
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833376 5-aminoalkyl and 5-aminocarbonyl substituted indole derivative useful for treatment of psychosis in a mammal
12/21/2004	US6833375 As inhibitors of the retinoic acid-metabolism, as drugs
12/21/2004	US6833366 Alpha v beta 3 and/or 5 integrin antagonists; reduced side effects
12/21/2004	US6833363 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
12/21/2004	US6833353 Inhibiting matrix metalloprotease (MMP) production using such as tacrolimus, cyclosporing A or 33-epi-chloro-33-desoxy-ascomycin
12/21/2004	US6833349 Therapy for skin disorders; psoriasis
12/21/2004	US6833348 Inhibiting apoptosis mediated by CD3 T-cell receptor or Fas/Fas-L systems; stimulating lymphocyte activity
12/21/2004	US6833264 Hyaluronan synthase gene and uses therof
12/21/2004	US6833140 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
12/21/2004	US6833132 Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity
12/21/2004	CA2317604C Matrix metalloprotease inhibitors
12/21/2004	CA2167926C Use of benzydamine in the treatment of pathological conditions caused by tnf
12/21/2004	CA2079968C Mono-fluorinated derivatives of n-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase
12/16/2004	WO2004108945A2 Oligonucleotide modulation of cell adhesion
12/16/2004	WO2004108927A1 Laminin 5b
12/16/2004	WO2004108907A1 Nerve cell obtained by electrically pulse-treating es cell
12/16/2004	WO2004108729A1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
12/16/2004	WO2004108724A1 Tricyclic compound
12/16/2004	WO2004108674A1 Amino alcohol derivative, medicinal composition containing the same, and uses of these
12/16/2004	WO2004108163A1 Method for preparing powder exhibiting low susceptibility to electrification
12/16/2004	WO2004108155A1 Cells used as carriers for bacteria
12/16/2004	WO2004108141A2 Bach-o-protein coupled receptor releated methods
12/16/2004	WO2004108133A2 Modulators of vr1 receptor
12/16/2004	WO2004108132A1 Staurosporine derivatives for hypereosinophilic syndrome
12/16/2004	WO2004108129A1 Stem cell invasion inhibitor
12/16/2004	WO2004108123A1 Preventive and/or remedy for kidney diseases
12/16/2004	WO2004108119A2 Use of atp or derivatives in medicine
12/16/2004	WO2003071922A3 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
12/16/2004	WO2003066666A3 Compositions and methods for treatment of vitamin d deficiency
12/16/2004	US20040254378 2-Methanesulfone group; Side effect reduction; Nonsteroidal Antiinflammatory
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254375 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
12/16/2004	US20040254371 New benzothiazine and benzothiadiazine compounds
12/16/2004	US20040254370 Peroxisome proliferators activated receptor regulator; useful for hypoglycemia, hypolipidemia, preventing and/or treatment of diseases associating metabolic disorders, atherosclerosis, cardiovascular diseases, syndrome x, cholestrol
12/16/2004	US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004	US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/16/2004	US20040254342 Substrates and assays for beta-secretase
12/16/2004	US20040254341 Human aspartyl protease peptide for use in identifying modulators for treatment and prevention of neurodegenerative and nervous system disorders; enzyme inhibitors
12/16/2004	US20040254339 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours
12/16/2004	US20040254245 Using extract of olive leaves; moisturizers; antiinflammatory agents; prevention of acne
12/16/2004	US20040254240 Anti-cancer nitro- and thia-fatty acids
12/16/2004	US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
12/16/2004	US20040254221 Viricides; anticancer agents; antiarthritic agents
12/16/2004	US20040254216 Inhibitors of p38
12/16/2004	US20040254213 Use of bicyclo compounds for treating alzheimer's disease
12/16/2004	US20040254212 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
12/16/2004	US20040254211 Alpha v integrin receptor antagonists
12/16/2004	US20040254203 Methods and compositions utilizing quinazolinones
12/16/2004	US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants
12/16/2004	US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease
12/16/2004	US20040254191 Antiinflammatory agents; autoimmune diseases; controlling tumor necrosis factor; immunosuppressants
12/16/2004	US20040254189 Jnk inhibitors
12/16/2004	US20040254186 Pyridylfurans and pyrroles as raf kinase inhibitors
12/16/2004	US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects
12/16/2004	US20040254184 Psychological disorders; antidepressants; anxiolytic agents; analgesics; antiinflammatory agents; central nervous system disorders
12/16/2004	US20040254177 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/16/2004	US20040254176 Hypotensive agents; cardiovascular disorders; antidiabetic agents; skin disorders;kidney disorders; headaches; vision defects; strokes; synergistic mixture of amlodipine, benazepril and hydrochlorothiazide; oral administering
12/16/2004	US20040254175 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents
12/16/2004	US20040254165 Vitiligo; skin cancer; control skin coloring
12/16/2004	US20040254161 New benzothiazine and benzothiadiazine compounds
12/16/2004	US20040254160 Benzothiazepine derivatives
12/16/2004	US20040254151 Osteoporosis, bone cancer; antiarthritic agents;paget's disease; antiinflammatory agents
12/16/2004	US20040254145 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
12/16/2004	US20040254144 Use of inhibitors of heparin-binding epidermal growth factor or inhibitors of its receptors for the preparation of drugs useful for treating myeloma
12/16/2004	US20040254137 Nucleotide sequences; for therapy of bone disorders, chondrondysplasis; biodrug; activation caspase signaling cascade
12/16/2004	US20040254129 In aqueous solution;prevent cell damage; mixture with drug or nitritional supplment
12/16/2004	US20040254123 Using benzylidene ascorbate in mixture with carrier
12/16/2004	US20040254122 increasing the tryptophan:large neutral amino acids ratio in blood by orally administering a rapidly digestible blend of no more than 40 g carbohydrate and a high tryptophan containing protein
12/16/2004	US20040254117 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
12/16/2004	US20040254107 Biphasic mixtures of glp-1 and insulin
12/16/2004	US20040254106 Modified factor ix
12/16/2004	US20040254098 Therapy, diagnosis, or electronic component
12/16/2004	US20040254096 Mucin synthesis inhibitors
12/16/2004	US20040253706 Substrates and assays for beta-secretase
12/16/2004	US20040253697 Nucleotide sequences coding epothilone polyketide synthase for use in generating fungicides, immunosuppressants and/or antitumor agents in microorganisms; bioreactors and heterologous gene expression
12/16/2004	US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders
12/16/2004	US20040253682 Immunloglobulin prostaglandin inhibitor for use in the treatment and prevention of arthritic and inflammatory bowel disorders
12/16/2004	US20040253681 Mitogenic oxygenase regulators
12/16/2004	US20040253674 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
12/16/2004	US20040253647 Evaluating modulators effectiveness as treatment for alzheimer's via quantifying amyloid precursor protein peptide cleavage products present after exposure agonist/antagonist

1 ... 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 ... 1564